Elsevier

Experimental Cell Research

Volume 247, Issue 1, 25 February 1999, Pages 84-93
Experimental Cell Research

Regular Article
Interleukin 1 Induces Multinucleation and Bone-Resorbing Activity of Osteoclasts in the Absence of Osteoblasts/Stromal Cells

https://doi.org/10.1006/excr.1998.4320Get rights and content

Abstract

Interleukin-1 (IL-1) is one of the most potent bone-resorbing factors involved in bone loss associated with inflammation. We previously reported that IL-1 prolonged the survival of multinucleated osteoclast-like cells (OCLs) formed in cocultures of murine osteoblasts/stromal cells and bone marrow cells via the prevention of spontaneously occurring apoptosis. It was reported that macrophage colony-stimulating factor (M-CSF/CSF-1) prolongs the survival of OCLs without the help of osteoblasts/stromal cells. The present study was conducted to determine whether IL-1 also directly induces the multinucleation and activation of OCLs. Mononuclear osteoclast-like cells (prefusion osteoclasts; pOCs) were purified using the “disintegrin” echistatin from cocultures of murine osteoblastic cells (MB 1.8 cells) and bone marrow cells. Both IL-1 and M-CSF prolonged the survival and induced the multinucleation of pOCs through their respective receptors. However, actin ring formation (a functional marker of osteoclasts) by multinucleated cells was observed in the pOC cultures treated with IL-1, but not those treated with M-CSF. We previously reported that enriched multinucleated OCLs as well as pOCs placed on bone/dentine slices formed few resorption pits, but their pit-forming activity was greatly increased by the addition of osteoblasts/stromal cells. Here, pit-forming activity of both pOCs and enriched OCLs placed on dentine slices was induced by adding IL-1, even in the absence of osteoblasts/stromal cells. M-CSF failed to induce pit-forming activity in pOC and enriched OCL cultures. These results indicate that IL-1 induces the multinucleation and bone-resorbing activity of osteoclasts even in the absence of osteoblasts/stromal cells.

References (40)

  • B.F. Boyce et al.

    Effects of interleukin-1 on bone turnover in normal mice

    Endocrinology

    (1989)
  • M. Gowen et al.

    An interleukin 1 like factor stimulates bone resorption in vitro

    Nature

    (1983)
  • J.A. Lorenzo et al.

    Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1

    Endocrinology

    (1987)
  • F.E. Dewhirst et al.

    Purification and partial sequence of human osteoclast-activating factor: Identity with interleukin 1β

    J. Immunol.

    (1985)
  • W.P. Arend et al.

    Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist

    J. Clin. Invest.

    (1990)
  • P. Seckinger et al.

    Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production

    J. Immunol.

    (1990)
  • R.B. Kimble et al.

    Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats

    J. Clin. Invest.

    (1994)
  • T.J. Chambers et al.

    Resorption of bone by isolated rabbit osteoclasts

    J. Cell Sci.

    (1984)
  • R. Baron et al.

    Cell-mediated extracellular acidification and bone resorption: Evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border

    J. Cell Biol.

    (1985)
  • Cited by (308)

    • Biodegradable magnesium incorporated microspheres enable immunomodulation and spatiotemporal drug release for the treatment of osteonecrosis of the femoral head

      2023, Composites Part B: Engineering
      Citation Excerpt :

      Researchers have revealed that the expression of IL-10 could promote the proliferation of MSCs [62,63], and with the assistance of BMP-2 [64], MSCs will finally differentiate into osteoblast for bone formation. However, the overexpression of pro-inflammatory cytokines, such as TNF-α and IL-1β, in the late stage could inhibit the proliferation of MSCs and promote the differentiation from macrophages to osteoclasts, resulting excessive bone resorption [65,66]. According to the results of this work and some previous studies, we reckon that Mg exerts immunomodulatory effects through the following two pathways: (1) The existence of Mg neutralizes the acid by-products produced by PLLA degradation.

    View all citing articles on Scopus

    D. D. BikleA. Negrovilar

    1

    To whom reprint requests should be addressed. Fax: (813)-3784-5555. E-mail:[email protected].

    View full text